Business, Free News Articles

New, Patented Device for Quick, Painless, Non-Invasive Elimination of Hemorrhoids Now Available with All Rights for Manufacture

LOS ANGELES, Calif. -- ProNova Partners, a seventeen-year-old California based Mergers and Acquisitions firm, has been commissioned to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive, device to eliminate hemorrhoids. Use of the device requires no anesthesia, is conducted in under 2 minutes, and can be performed in any medical setting: a doctor's office, a surgery center, an endo suite, or a hospital.

This technology has yielded a painless, non-invasive, no anesthesia needed device to eliminate hemorrhoids in under 2 minutes. The procedure can be performed in any medical setting.

"Over half of adults suffer from this affliction at one time or another," stated Rick Carlson founder and CEO of ProNova Partners. "This Doctor developed device offers a fast, painless and permanent solution."

Carlson's firm has helped the expansion or sale of some 400 companies in a wide variety of market segments.

This latest commission for ProNova is designed to structure movement of the patent, sale, and manufacturing rights of a much-needed device to an outside company. The goal is quickly move the technology out and into the medical marketplace. The product, developed and currently sold on a limited basis in the US, was originated by a gastroenterologist. It is currently sold directly to physicians of different specialties, including gastroenterologists, colorectal surgeons, GYNs, urologists and primary care physicians. The biggest targeted audience is gastroenterologists.

"Huge numbers of patients now no longer need to use ineffective creams or receive painful, invasive surgery," concluded Carlson. "This device offers a permanent, painless solution."

For detailed information go to: https://pronovapartners.com/engagement/patented-medical-device-company-for-hemorrhoid-removal-for-sale/

Related link: https://www.pronovapartners.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment

AI Radiology and Emerging Medical Technology Venture Capital Investment Group Now Open to Outside Participation

LOS ANGELES, Calif. -- Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.

"This venture capital investment partnership was founded in 2018," announced Rick Carlson, CEO of ProNova Partners. "On behalf of their members, they find and invest in game changing, cutting edge, emerging companies specializing in Artificial Intelligence Radiology Imaging and other Medical Technologies."

"The group is owned and operated by three managing partners with broad ranging domain expertise," continued Carlson. "We are very pleased to work with such a qualified group. They are finding and investing at the early stages in firms at the razor's edge of Artificial Intelligence in medical technology." Carlson's company has assisted the expansion or sale of some 400 companies in a wide variety of market segments.

"The investment group has already seen high quality, sector specific deal flow, and boasts of a robust current portfolio of investments in leading edge technologies," concluded Carlson.

"The investment firm's distinguished Managing Partners' combined credentials span venture capital investment expertise. This includes domain expertise in radiology covering a broad range of aspects of radiology and MRI imaging, entrepreneurship, artificial intelligence, and other emerging medical technologies. Their combined knowledge and experience establish them as ideally suited to spearhead the formation of a selected group of physician and non-physician investors plus providing groundbreaking leadership in early stage company investments in the AI/Imaging/Radiology sector."

For detailed information go to: https://pronovapartners.com/engagement/ai-radiology-and-emerging-technology-firm-for-sale/

Related link: https://www.pronovapartners.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, VAR and IT Consulting

By Light Awarded $82M VA Contract

MCLEAN, Va. -- By Light Professional IT Services LLC (By Light) has been awarded the My HealtheVet (MHV) Development, Security and Operations (DevSecOps) contract by the Department of Veterans Affairs (VA). Valued at $82M over five (5) years, this contract provides for the continued support and development of VA's Veteran-facing Electronic Health portal.

"Team By Light considers it an honor to continue our long and valued partnership with VA to provide innovative DevSecOps solutions to the MHV Program with a Scaled Agile and Digital Services Playbook approach," says Bill Sackewitz, By Light Senior VP for Digital Transformation. "Our team has invested heavily in DevSecOps, User Centered Design, and Lean Agile Product Delivery methods to hasten and improve value delivered to the customer. Our mission in By Light's Chief Strategy Office is to help our teams and our clients adopt new ways of working that lead to better user outcomes."

The MHV patient portal provides healthcare communications and coordination for millions of Veterans, caretakers, and providers. The MHV program is a nationwide initiative intended to improve the overall health of Veterans. It provides an eHealth portal, a secure environment where Veterans can view and manage their personal health record online and access health information, health assessments, and electronic services. Online health resources will enable and encourage patient/provider collaboration, as clinicians will be able to communicate with Veterans more easily.

The online environment will complement existing Veterans Health Administration (VHA) clinical business practices and be transformational in the way health care is delivered and managed. Like other VA systems MHV will eventually be integrated into VA.gov that will be accessible to Veterans from MHV, or other web portals as identified by the government.

"Our team has been supporting the development and expansion of MHV since 2012 and is dedicated to furthering the evolution of one of the U.S. Government's largest and most important technical programs benefiting those who have served," states Matt Bain, MHV Program Director at By Light. "We are very proud of our ten years of supporting MHV eHealth delivery capabilities and look forward to further deliver new and innovative solutions that support VA's Office of Connected Care ecosystem and improve the experience for Veterans and their care givers."

"We are happy to have By Light back and to continue the great work we have done together over the past decade," notes Greg Kirk, MHV Program Manager. "The MHV solution will continue to evolve with the DevSecOps contract, and the results will ultimately deliver better products and services faster to the Veterans."

About By Light:

By Light Professional IT Services LLC (https://www.bylight.com) headquartered in McLean, Virginia, is an ISO 9001, 20000-1, and 27001 registered and CMMI Level 3 rated systems integrator that provides innovative IT, infrastructure solutions, and full spectrum cyberspace operations for U.S. Federal and State Government Agencies. By Light has extensive success with VA and across the DoD, successfully implementing technical solutions that integrate commercial best practices to meet the needs of government.

Related link: https://www.bylight.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Alliances and Partnerships, Business, Free News Articles

MediSked Partners with Medicaid Health Plans of America (MHPA) to Further Support Managed Care

ROCHESTER, N.Y. -- Furthering its dedication to providing technology solutions to payers in the health and human services industry, MediSked has signed a corporate partnership agreement with Medicaid Health Plans of America (MHPA), MediSked announced today.

Founded in 1995, MHPA is the leading national trade organization focusing solely on the interests of the Medicaid managed care industry. MHPA's members include over 130 health plans, known as managed care organizations (MCOs), that serve over 40 million Medicaid enrollees in 40 states, the District of Columbia and Puerto Rico.

"MHPA is thrilled to have MediSked join us as a Bronze Partner," said Craig A. Kennedy, MHPA President and CEO. "For nearly two decades MediSked has been an invaluable technology resource and partner to health and human service organizations across the United States, changing lives for the better and increasing efficiency, as well as driving innovations that support the health care community. We look forward to working with them in our efforts to increase access to quality, affordable health care for all."

MediSked is one of the few premier technology vendors that has in-depth experience in supporting statewide Medicaid transformation using integrated end-to-end solutions that were built on the foundation of the federal Health Home State Plan.

As a Bronze Partner, MediSked will be working in partnership with MHPA to promote policy and operational solutions that enhance the delivery of quality care for Medicaid enrollees through improved access and cost-effective services.

"We are excited to join MHPA in our shared dedication to improving outcomes and quality of life for Medicaid-enrolled individuals across the country," said Rachel Hendrickson, Associate Director of Strategic Growth at MediSked.

About MediSked:

MediSked is the leading brand in holistic solutions that improves lives, drives efficiencies, and generates innovations for health and human service organizations that support our community. MediSked solutions combine to provide innovative, person-centered technology that improves outcomes and quality, while reducing costs for individuals receiving home and community-based services and long-term services and supports through government & oversight, care coordination/payer and provider agencies. MediSked has supported clients across the United States since 2003.

Learn more at https://www.medisked.com/.

Related link: https://www.medisked.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Funding and Investment

Neurosoft Bioelectronics Receives Nearly $3 Million in Funding

NEW YORK, N.Y. -- Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant. Additionally, the firm secured a $100,000 convertible note from the Fongit Innovation Fund.

Proceeds will fund continued development of the company's soft flexible electrodes to be marketed as SOFT ECoG™, a family of implantable devices which can seamlessly interface with the brain. The novel devices are up to 1000x softer and 2x thinner than clinical electrodes, with integrated electrode sites up to 100x smaller, making them suited for high-resolution recording and stimulation of the brain for up to thirty days. Their conformability and softness make them ideally suited for placement in the sulci of the brain - hard to reach areas of the brain where many disorders may best be treated. The deep folds of a sulcus are inaccessible for other electrodes while SOFT ECoG can be safely and precisely placed for stimulation and recording.

"Given that 70% of the surface of the brain is buried in sulci, it was critical to develop a technology that could safely and effectively work in those spaces," said Neurosoft Bioelectronics' CEO, Nicolas Vachicouras, Ph.D. "We're eager to put these significant funds toward clinical testing and regulatory approval of SOFT ECoG in the upcoming months, which will simultaneously drive progress of SOFT TINNIT. Together, these products have the potential to bring relief to epilepsy, brain tumor, and tinnitus patients, and in the future will impact those living with other neurological disorders such as deafness, blindness, tetraplegia, and chronic pain."

Vachicouras will present an update about the company and technology at the Bioelectronic Medicine Forum in New York today.

Most of the funds are designated for the further development of SOFT ECoG however, the innovations made will simultaneously advance the company's second product, SOFT TINNIT™. SOFT TINNIT is a chronic implant to perform closed-loop neuromodulation of the cortex to provide relief for patients suffering from severe tinnitus. Severe tinnitus, which has no cure, affects more than 7 million people in the U.S. and Europe.

Learn more: https://www.neurosoft-bio.com/technology

About Neurosoft Bioelectronics

Neurosoft Bioelectronics Ltd. is a Swiss medtech spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL). Neurosoft Bioelectronics develops next generation soft implantable electrodes to interface with the brain for the treatment of severe neurological disorders. Its main product is a fully implantable closed-loop Brain-Computer Interface (BCI) to treat severe tinnitus, a condition that affects 7M people in the US and Europe, of which 7% attempt suicide every year. It is also developing a family of subdural electrodes intended for monitoring during brain tumor and epilepsy resection surgery.

Learn more at: https://www.neurosoft-bio.com/

RELATED LINKS:

https://neurotechreports.com/pages/bioelectronic-medicine-forum.html

Related link: https://www.neurosoft-bio.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Key Entrepreneurs to Present at 2022 Bioelectronic Medicine Forum

NEW YORK, N.Y. -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

Entrepreneur presenters at the conference include Attila Borbath, CEO of Synergia Medical, a European firm developing an optical vagus nerve stimulation system, Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, Jennifer Ernst, CEO of Tivic Health, Manfred Franke, CEO of Neuronoff Inc., and Anuj Bhardwaj, CEO of SecondWave Systems Inc.

Peter Staats, a bioelectronic medicine pioneer and co-founder and chief medical officer of electroCore Medical, will keynote the conference. Dr. Staats is internationally recognized for his work in developing and implementing minimally invasive procedures for a number of disorders, including COVID, and his patents have led to the use of novel pharmacologic agents. He is a past President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society.

Other speakers at the 2022 event include Marom Biksom, professor of biomedical engineering at City College of New York, Imran Eba, partner at Action Potential Venture Capital, Chihiro Hosoya, head of venture management and business development at Astellas Pharma, Eric Hudak, program director at the National Institutes of Health, and Hannah Claridge from TTP plc in the U.K.

Other sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties.

MST is the Platinum Sponsor of this year's event, while Valtronic is the Silver Sponsor.

Key topics will include promising new indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This fifth-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry."

For more information on the 2022 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

RELATED LINKS:
https://www.neurotechreports.com/

Related link: http://www.neurotechreports.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Awards and Honors, Business, Free News Articles, Software

MediSked Named Top 10 Population Health Management Solution by Healthcare Tech Outlook

ROCHESTER, N.Y. -- MediSked, LLC was named as one of the Top 10 Population Health Management Solution Companies of 2021 by Healthcare Tech Outlook, a print and digital platform offering healthcare decision makers critical information on adopting, innovating and building new programs and approaches to enhance their capability to provide care.

The Top Population Health Management Solutions awarded by Healthcare Tech Outlook is an annual listing of ten companies that are at the forefront of providing Population Health Management solutions and impacting the industry.

MediSked has been a trusted technology partner to health and human services organizations across the country since 2003, delivering comprehensive Software as a Service (SaaS) solutions via a person-centered technology model. MediSked offers a full-featured, modular software ecosystem for agencies in the home and community-based services (HCBS) and long-term services and supports (LTSS) industries.

MediSked's population health management offering is distinctive from others in that MediSked is one of the few premier technology vendors that has in-depth experience in supporting statewide Medicaid transformation. With MediSked's population health management solution suite, agencies can generate extensive analytics to identify opportunities that improve individual and population-level outcomes.

MediSked's data warehouse and commitment to improving whole-person care allowed the company to identify and share vaccination rates among individuals with intellectual and developmental disabilities (IDD) and discover the correlation between smokers and opting out of receiving a COVID-19 vaccine. Additionally, MediSked found that with good care coordination, anxiety and needs were measurably improved during the pandemic.

To view MediSked's award in Healthcare Tech Outlook, visit healthcaretechoutlook.com.

About MediSked:

MediSked is the leading brand in holistic solutions that improves lives, drives efficiencies, and generates innovations for health and human service organizations that support our community. MediSked solutions combine to provide innovative, person-centered technology that improves outcomes and quality, while reducing costs for individuals receiving home and community-based services and long-term services and supports through government & oversight, care coordination/payer and provider agencies. MediSked has supported clients across the United States for 18 years and is number 1068 on the 2020 list of Inc. 5000 Fastest Growing Companies.

Learn more at: https://www.medisked.com/

MULTIMEDIA:

VIDEO (YouTube) https://youtu.be/Ve4QVBZoMBc

RELATED LINKS:

https://www.medisked.com/wp-content/uploads/2021/11/2021-AADMD-Conference-Presentation.pdf

https://population-health-management.healthcaretechoutlook.com/vendor/medisked-futureready-solutions-for-long-term-services-and-support-cid-2281-mid-206.html

Related link: https://www.medisked.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Advertising and Marketing, Awards and Honors, Business, Free News Articles, Software

FlexCare Digital Health Honored with Four Awards at the Annual w3 Awards

ATLANTA, Ga. -- With more than 3,000 entries from around the globe, The Academy of Interactive and Visual Arts just announced the winners of its 16th Annual w3 Awards. FlexCare Digital Health, a leading provider of online and on-demand healthcare delivery, brought home a total of four awards and was recognized in the Mobile Apps and Mobile Features' categories.

The w3 Awards serves to illuminate creative excellence on the Internet and recognizes professionals who handle the creative and marketing acumen behind award-winning websites, video, marketing, mobile, social media and podcasts. These awards are sanctioned and judged by the Academy of Interactive and Visual Arts, an invitation-only body consisting of top-tier professionals from a "Who's Who" of acclaimed media, advertising and marketing forums.

FlexCare Digital Health received gold awards in the following categories:

- Mobile Apps and Sites: Mobile Site Redesign for Mobile

- Mobile Features: Best Visual Design-Aesthetic for Mobile

- Mobile Features: Best Interface for Mobile

It also received a silver award in:

- Mobile Features: Best Visual Design - Function for Mobile

As one of the leading providers of digital health solutions in the U.S., FlexCare Digital Health is transforming healthcare by providing digital health services that benefit both employers and employees. By delivering immediate access to a variety of digital health providers via its cloud-based proprietary online portal and mobile app, FlexCare makes it possible for members to connect seamlessly via phone, text, secure video or app.

About FlexCare Digital Health

FlexCare Digital Health is a leading provider of online and on-demand healthcare delivery services to private and public employers, associations, brokers, school systems and more.

By using Digital Health services instead of more expensive urgent care and ER visits, FlexCare cuts unnecessary costs and keeps members smiling (instead of waiting).

Its core offerings include: Virtual Primary Care, Telemedicine, Dermatology, Behavioral Health Counseling, TeleDentistry, Caregiver/Companionship Support, TeleSpine and other digital health services.

For more information, visit: https://flexcare.com/

About w3 Awards

The w3 Awards honors creative excellence on the web and recognizes the people behind award-winning sites, marketing programs, social content, mobile site/apps, and online video. In honoring the best of the web, the w3 Awards is the first major web competition to be accessible to the biggest agencies, the smallest firms and everyone in between. Small firms are as likely to win as Fortune 500 companies and international agencies.

SOCIAL MEDIA:

Twitter: https://twitter.com/FlexCarePlus

Facebook: https://www.facebook.com/flexcareplus

LinkedIn: https://www.linkedin.com/company/flexcare-telemedicine/?viewAsMember=true

MULTIMEDIA

Sneak Peek at our award-winning app: https://youtu.be/Enusc-PoBic

Related link: http://flexcare.com/

This news story was published by the Neotrope® News Network - all rights reserved.